Pharmaceutical Services | Home Page

News

- 15/10/2021 EMA starts rolling review of Evusheld (tixagevimab and cilgavimab)

- 13/10/2021 EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG

- 12/10/2021 EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19

- 05/10/2021 Comirnaty and Spikevax EMA recommendations on extra doses and boosters

- 28/09/2021 EMA evaluating data on booster dose of COVID-19 vaccine Spikevax

- 06/09/2021 EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

- 02/09/2021 ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines

- 16/08/2021 EMA starts evaluating use of RoActemra in hospitalised adults with severe COVID-19

- 05/08/2021 Second ECDC and EMA update on COVID-19

- 26/07/2021 COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU